Magnesium Citrate

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Magnesium Citrate
Generic name: MAGNESIUM CITRATE ORAL SOLUTION
Manufacturer: WALGREEN COMPANY
Product type: HUMAN OTC DRUG
SPL set ID: 4ffe54ae-3126-ba58-e063-6294a90a8877
SPL ID: 570cb4e2-4b6b-4381-e063-6394a90a0259
Version: 2
Effective date: 2026-07-20
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:56:07

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M007	openfda.application_number
brand name		Magnesium Citrate	openfda.brand_name
generic name		MAGNESIUM CITRATE ORAL SOLUTION	openfda.generic_name
manufacturer name		WALGREEN COMPANY	openfda.manufacturer_name
ndc	package	0363-6350-98	openfda.package_ndc
ndc	product	0363-6350	openfda.product_ndc
ndc11	package	00363635098	derived:openfda.package_ndc
rxcui		1052760	openfda.rxcui
spl id		570cb4e2-4b6b-4381-e063-6394a90a0259	id
spl set id		4ffe54ae-3126-ba58-e063-6294a90a8877	set_id
unii		RHO26O1T9V	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Ask a doctor before use if you have ■ Kidney disease ■ a magnesium restricted diet ■ Abdominal pain, nausea, or vomiting ■ Noticed a sudden change in bowel habits that persists over a period of 2 weeks ■ Already used a laxative for a period longer than 1 week

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.